ScientiaLux
Index
QF-Pro Home › QF-Pro Glossary › Functional Biomarkers
Paradigm Shift

Functional Biomarkers

Biomarkers measuring molecular engagement state rather than expression–predicting therapeutic outcomes where abundance-based biomarkers fail.

View
Definition
Functional biomarkers measure molecular activity and engagement rather than protein abundance. While expression-based biomarkersLoading... (IHCLoading...) answer "is the protein present?", functional biomarkers answer "is the protein doing its job?" This distinction is clinically decisive: expression often fails to predict therapeutic response because presence does not equal function.
Video Segments
Related Segments
Technology Comparison: Coloc vs PLA vs QF-Pro
Related
QF-Pro Score: How FRET Efficiency Is Calculated
Related
Post-Translational Modifications via aFRET
Related
Drug Dose-Response by FRET
Related
The 2.13% Clinical Cutoff
Related
Activity over abundance
Measures what proteins do
Clinical correlation
iFRET predicts survival
Expression fails
IHC shows p=0.87
Physics-based threshold
FRET distance constraint

The Paradigm Shift

For decades, companion diagnosticsLoading... have relied on expression-based biomarkers–measuring how much of a target protein is present. PD-L1 IHC exemplifies this approach: tumor proportion score reports the percentage of cells expressing PD-L1.

Yet clinical data consistently reveal the limitation: in NSCLC, only ~41% of 'high PD-L1' patients respond to pembrolizumab. The 59% who don't respond met the expression criterion but lacked functional checkpoint engagement.

Functional biomarkers address this gap by measuring molecular activity–receptor-ligand binding, kinase activation, pathway engagement. The question shifts from "is it there?" to "is it working?"

Simplified

The Old Question: "Is the protein there?" (Expression)

The New Question: "Is the protein working?" (Function)

Why It Matters: A protein can be present but inactive. Or present at low levels but highly active. Only functional measurement captures what's actually driving biology.

FRET as the Enabling Technology

Forster Resonance Energy TransferLoading... (FRET) provides the physical basis for functional biomarker detection. FRET occurs only when donor and acceptor chromophoresLoading... are within 1–10 nanometers–the distance at which proteins must be to genuinely interact.

Combined with Fluorescence LifetimeLoading... Imaging Microscopy (FLIM), FRET efficiencyLoading... becomes a quantitative, intensity-independent metric. This is critical: functional biomarkers must work regardless of expression level. A low-expression tumor with active checkpoint engagement is biologically different from a high-expression tumor without engagement.

The QF-ProLoading... platform implements this approach in FFPE tissueLoading... using standard pathology workflows, enabling clinical translation of functional biomarker measurement.

Simplified

How FRET Enables Function Measurement: FRET detects when proteins are within 1-10nm—close enough to actually interact or be in an active conformation.

The Evidence: When PD-1/PD-L1 interaction was measured by FRET (instead of PD-L1 expression), survival prediction improved from P=0.87 (useless) to P=0.05 (significant).

QF-Pro as the Enabling Platform

Clinically Validated

Platform Validation: QF-Pro provides the technological foundation for functional biomarker measurement in clinical tissue. Validated applications include:

Checkpoint engagement: PD-1/PD-L1 interaction predicts survival (P=0.05[3]) where expression fails (P=0.87[3]).
Kinase activation: PKB/Akt activation predicts survival in breast cancer and ccRCC where expression shows no correlation.
Treatment response: iFRET efficiency changes correlate with pathologic response in neoadjuvant settings.

Click citation numbers to view full references in QF-Pro Applications & Clinical EvidenceLoading...

Simplified

The platform: QF-Pro enables functional biomarker measurement across multiple applications: checkpoint engagement, kinase activation, and treatment response monitoring. Each application demonstrates superior predictive power versus expression-based testingLoading....

Expression-Based Biomarkers
"Is it present?" ' Variable correlation
Subjective scoring, operator-dependent
Expression != Function
Functional Biomarkers
"Is it engaged?" ' Mechanism-direct
Quantitative, physics-based threshold
Activity predicts response

Clinical Validation Evidence

  • PD-1/PD-L1Loading... in melanoma (176 patients): iFRETLoading...-measured interaction correlated with overall survival (P=0.05); PD-L1 expression showed no correlation (P=0.87)
  • Clear cell RCC: iFRETLoading... detected PD-1/PD-L1Loading... interaction in 10 of 11 patients classified 'PD-L1 negative' by IHCLoading...–functional engagement invisible to expression-based assayLoading...s
  • PKB/AktLoading... in breast cancer: Activation state (FRET efficiency 2.5%–6.0%) predicted survival; expression by IHC showed no prognostic correlation
  • Neoadjuvant TVEC: Complete responders showed significantly increased iFRETLoading... efficiency post-treatment; non-responders showed unchanged values–differences not reflected by PD-L1 expression

Connected Terms

Share This Term
Term Connections